Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 77pembrolizumab 65Bevacizumab 58Carboplatin 57Specimen Handling 49Magnetic Resonance Spectroscopy 40Cisplatin 35olaparib 31Gemcitabine 26liposomal doxorubicin 24Biopsy 22Taxes 18Cyclophosphamide 18Topotecan 17Nivolumab 17Immunoglobulin G 15Doxorubicin 15niraparib 14Letrozole 14Disulfides 14lenvatinib 13fludarabine 13atezolizumab 12Surveys and Questionnaires 12Radiotherapy 11Drug Therapy 11abemaciclib 10Platinum 10Docetaxel 10Brachytherapy 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
human papillomavirus vaccine, TA × Gynecologic × 90 days × Clear all
NCT06315257 2026-05-20

A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Recruiting
32 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡